Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An Alzheimer's Disease-Derived Biomarker Signature Identifies Parkinson's Disease Patients with Dementia.

PloS one - 1 Jan 2016

Berlyand Yosef, Weintraub Daniel, Xie Sharon X, Mellis Ian A, Doshi Jimit, Rick Jacqueline, McBride Jennifer, Davatzikos Christos, Shaw Leslie M, Hurtig Howard, Trojanowski John Q, Chen-Plotkin Alice S

Abstract excerpt

Biomarkers from multiple modalities have been shown to correlate with cognition in Parkinson's disease (PD) and in Alzheimer's disease (AD). However, the relationships of these markers with each other, and the use of multiple markers in concert to predict an outcome of interest, are areas that are much less explored. Our objectives in this study were (1) to evaluate relationships among 17 biomarkers previously...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloid beta-Peptides
Share to Apolipoproteins E

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cross-Sectional Studies

Share to Dementia

Share to Logistic Models

Share to Parkinson Disease

Share to Peptide Fragments

Share to tau Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 26812251
DOI: 10.1371/journal.pone.0147319
PMCID: PMC4727929

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An Alzheimer's Disease-Derived Biomarker Signature Identifies Parkinson's Disease Patients with Dementia.PMID 26812251Read ↗

APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease.Semantic proximity Read ↗

CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study.Semantic proximity Read ↗

High-sensitivity plasma proteomics reveals disease-specific signatures and predictive biomarkers of Alzheimer’s disease phenotypes in a large mixed dementia cohortSemantic proximity Read ↗

High-sensitivity plasma proteomics reveals disease-specific signatures and predictive biomarkers of Alzheimer's disease phenotypes in a large mixed-dementia cohort.Semantic proximity Read ↗

Genome-wide meta-analysis of CSF biomarkers in Alzheimer’s disease and Parkinson’s disease cohortsSemantic proximity Read ↗

Machine learning-based prediction of cognitive outcomes in de novo Parkinson’s diseaseSemantic proximity Read ↗

Prediction, prognosis and monitoring of neurodegeneration at biobank-scale via machine learning and imagingSemantic proximity Read ↗

Biomarker characterization of clinical subtypes of Parkinson DiseaseSemantic proximity Read ↗

Diagnostic biomarkers for Parkinson's disease at a glance: where are we?Semantic proximity Read ↗

Integrating Machine Learning Pipelines for Multimodal Biomarker Prediction in Alzheimer’s and Parkinson’s Disease: A Component of the Neurodiagnoses FrameworkSemantic proximity Read ↗

Identification of a simple and novel cut-point based CSF and MRI signature for predicting Alzheimer’s disease progression that reinforces the 2018 NIA-AA research frameworkSemantic proximity Read ↗

A blood‐based multi‐pathway biomarker assay for early detection and staging of Alzheimer's disease across ethnic groupsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.